http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
1988 년 가을 강원도 영서지역에서 발생한 쭈쭈가무시병 24 예의 임상적 관찰
최동성(Dong Seong Choi),이광훈(Kwang Hoon Lee),박진현(Jin Hyun Park),신계철(Gae Chul Shin),조한선(Han Sun Jo),심영학(Young Hak Shim),윤갑준(Gap Jun Yun),백일기(Ill Ki Baek),임채선(Chae Sun Im),호휘남(Whi Nam Ho) 대한내과학회 1989 대한내과학회지 Vol.37 No.3
N/A We obserbed 24 cases of tsutsugamushi disease occur- ring in the Gang-Won-Do area from September to October 1988, which were confirmed by indirect immunofluorescent antibody test, and analysed their clinical findings. On physical examination eschars which can be a clinical clue to tsutsugamushi disease in the early stage of infection were recorded in 11 cases (45%). Common laboratory features included thrombocytopenia in 19 cases (95/o), and increased SGOT in 22 cases (92%), SGPT in 49 cases (79%), LDH in 19 out of 20 cases (95%) tested, CK in 7 out of 20 cases (35%) tested and serum ADA level in 12 of 13 cases (92%) tested. Serum fibrinogen was decreased in 5 of 13 cases (38%) tested, FDP was positive in 8 of 13 cases (62%) tested and prolonged prothrombin time was observed in 9 cases (38%). When IgM and IgG titers were measured separately, two distinct responses were seen. The IgM titers gradually declined during the period from 14-40 days. The IgG responses in the same patients developed more slowly. In our study, tsutsugamushi disease was a mild to severe febrile illness of 1 to 2 weeks duration. We think that more concern about tsutsugamushi disease is necessary because of possible mortality in poorly treated cases as well as a need for more precise differential diagnosis of acute febrile illness.
수용액상에서 Infrared Spectra를 이용한 HPDDA, MBDDA, BUDDPA의 특성에 관한 연구
김일출,김광음,도길명,최보영 慶南大學校 附設 基礎科學硏究所 1995 硏究論文集 Vol.7 No.-
Infrared Spectra of aqueous solution of HPDDA(Heptyldithiodiacetic acid), MBDDA(4-Methoxybenzmethyldithiodiacetic acid), and BUDDPA(Butyldithiodipropionic acid) are reported at various PH values. On the basis of the antisymmetric stretching bands of the ionized and un-ionized carboxyl group, the structures of the free-ligands are inferred. A approach to the study of these structures are compared with the results of potentiometric titration curve and IR Spectra studies.
B형 간염 동반 원발성 간암 환자에서의 CYP2D6와 NAT2 다형현상에 관한 연구
신동일,이광수,최연남,황기은,조율희 한양대학교 의과대학 2001 한양의대 학술지 Vol.21 No.2
The CYP2D6 and N-acetyltransferase (NAT2) are polymorphic enzymes which are expressed in the hepatocyte in a genotype-determined manner. CYP2D6 and NAT2 are known to be involved in the inactivation and activation of various mutagens and carcinogens, respectively. The activities of the two enzyme systems are associated with the genetic susceptibility of many human cancers. This study was performed to determine the genotype frequencies of the two enzyme systems in primary hepatocellular carcinoma patients and healthy controls. One hundred healthy controls and 55 liver cancer patients were analyzed by polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP). The results are as followings:1. In the healthy controls, CYP2D6 wild type allele frequency was 0.985 and CYP2D6^*4 frequency was 0.015, and no CYP2D6 poor-metabolizer was detected. No significant differences were found in hepatocellular carcinoma patient group. 2. Frequencies of F, S1, S2 and S3 alleles of NAT2 system were 0.725, 0.01, 0.14 and 0.125 in controls, respectively. The genotype frequencies were found to be 0.91 of rapid acetylator and 0.09 of slow acetylator. No significant differences were found in hepatocellular carcinoma patient group. 3. These results suggest that the distribution of CYP2D6 and NAT2 polymorphisms is very unique in Korean populations characterized by extremely low frequency of CYP2D6 poor-metabolizer and NAT2 slow acetylator. CYP2D6 and NAT2 polymorphisms seemed not to play an important role in the hepatic carcinogenesis in Korean population.
N 주개 리간드를 이용한 시스-디니트로실몰리브덴 착물(Ⅱ)의 합성과 특성에 관한 연구
김일출,김광음,도길명,최보용 慶南大學校 附設 基礎科學硏究所 1995 硏究論文集 Vol.7 No.-
The reactions of [(Mo(No)₂Cl₂)₂] with unidentate ligands in CH₂Cl₂ solvent afforded monomeric complexes [Mo(No)₂L₂Cl₂]. [Mo(No)₂L₄](CIO₄)₂ Was obtained by reaction of unidentate with [Mo(No)₂L₂Cl₂] in acetone solvent. 2.2'-bipyridine(bipy), 1.10-phenanthroline(phen), ρ-phentadine(ρ-phe), ο-toludine (ο-tol) were used as coordinating ligands. These dinitrosylmolybdenum complexes are prepared and characterized by elemental analysis, ¹H-NMR, Infrared, and UV-Visible spectroscopy. The infrared spectra indicate that the NO groups occupy cis-positions of the octahedral.
Effects of Sagunjatang on Concanavalin A - Induced Lymphocytes
Choi,Gi-soon,Hwa,Yoon-moon,Kang,Chul-hun,Kim,Kwang-ho,You,Seung-min,Ho,Soon-tae,Min,Byung-ill INSTITUTE OF ORIENTAL MEDICINE KYUNG-HEE UNIVERSIT 1998 JOURNAL OF ORIENTAL MEDICINE Vol.3 No.1
In order to investigate the effects of Sagunjatang on lympocytes induced by concanavalin A (Con-A), cell viability, cell proliperation, and production of interleukin 2 (IL-2) of the lypocytes from mice were studied. The lympocytes from spleens of BALB/C strain mice were cultured in a culture medium and treated with Sagunjatang. The cell viability was measured using trypan dye exclusion method at 0, 24, 48, and 72 hours after the treatment. For the effects of Sagunjatang on the cell proliferation, the cells were treated with Sagunjatang or concanavalin A (Con-A) and cultured for 48 hours. Then, in the presence of 3H-thymidine, the cells were cultured of an additional 18 hours and were used for determenation of the radioactivity. IL-2 production was illusidated by ELISA at 48 hours after the cells were treated with Sagunjatang or concanvalin A (Con A). Sagunjatang did not affect on the cell viability and it alone had no effects on lympocyte proliferation or IL-2 production whereas concanavalin A demonstrated significant effects. However, in the presence of concanavalin A, Sagunjatang further enhanced lympocyte proliferation and IL-2 production of lympocytes, which were induced by concanavalin A alone. This result indicates that Sagunjatang fortifies the function of concanavalin A on lympocyte proliferation.